Key Takeaways
- • Congressman Steve Cohen (TN-9) announced $2,543,243 in aggregate NIH grants distributed between the University of Tennessee Health Science Center (UTHSC) and St. Jude Children's Research Hospital for neuroscience and neurological disease research.
- • UTHSC received two grants totaling $659,405: $460,908 for research into cholinergic modulation of olfactory coding under Dr. Max L. Fletcher, and $198,497 for early communication research in Tuberous Sclerosis Complex (TSC) under Dr. Tanjala Trinette Gipson.
- • St. Jude received $455,000 from the National Institute of Neurological Disorders and Stroke for research into the LRRK2 gene mutations associated with familial and sporadic Parkinson's disease, directed by Dr. Chia-Hsueh Lee.
- • The funding targets high-impact neuroscience research, with particular emphasis on understanding disease mechanisms in Alzheimer's, Parkinson's, autism spectrum disorder, and rare genetic conditions, positioning these institutions as centers for neurological research advancement.
Summary
Congressman Steve Cohen announced $2.54 million in National Institutes of Health grants to two Memphis-based research institutions on July 30, 2026. The funding, totaling $2,543,243, was distributed to the University of Tennessee Health Science Center and St. Jude Children's Research Hospital, with the majority directed toward neuroscience research addressing major neurological conditions.
UTHSC secured $659,405 across two distinct research initiatives. The first award of $460,908 funds research into cholinergic modulation of olfactory coding led by Dr. Max L. Fletcher from the National Institute on Deafness and Other Communication Disorders. This work examines how acetylcholine and cholinergic signaling affect olfactory sensation, with particular relevance to early disease detection. Olfactory dysfunction serves as an early indicator of Alzheimer's and Parkinson's diseases, making this research strategically important for understanding neurodegeneration progression. The second UTHSC grant of $198,497 supports research into early communication patterns in Tuberous Sclerosis Complex (TSC) and autism spectrum disorder prediction, directed by Dr. Tanjala Trinette Gipson. TSC, a rare genetic disorder characterized by non-cancerous brain tumors, presents significant comorbidity with autism spectrum disorder in approximately 50% of cases. This study aims to identify language development markers that predict language outcomes and autism severity.
St. Jude Children's Research Hospital received $455,000 from the National Institute of Neurological Disorders and Stroke for research on the LRRK2 gene, directed by Dr. Chia-Hsueh Lee. LRRK2 mutations represent among the most common genetic associations with both familial and sporadic Parkinson's disease, making this research directly relevant to understanding a major neurodegenerative condition affecting millions globally. The consolidated grant distribution reflects federal prioritization of neuroscience research with translational potential for understanding disease mechanisms and improving clinical outcomes.
UTHSC secured $659,405 across two distinct research initiatives. The first award of $460,908 funds research into cholinergic modulation of olfactory coding led by Dr. Max L. Fletcher from the National Institute on Deafness and Other Communication Disorders. This work examines how acetylcholine and cholinergic signaling affect olfactory sensation, with particular relevance to early disease detection. Olfactory dysfunction serves as an early indicator of Alzheimer's and Parkinson's diseases, making this research strategically important for understanding neurodegeneration progression. The second UTHSC grant of $198,497 supports research into early communication patterns in Tuberous Sclerosis Complex (TSC) and autism spectrum disorder prediction, directed by Dr. Tanjala Trinette Gipson. TSC, a rare genetic disorder characterized by non-cancerous brain tumors, presents significant comorbidity with autism spectrum disorder in approximately 50% of cases. This study aims to identify language development markers that predict language outcomes and autism severity.
St. Jude Children's Research Hospital received $455,000 from the National Institute of Neurological Disorders and Stroke for research on the LRRK2 gene, directed by Dr. Chia-Hsueh Lee. LRRK2 mutations represent among the most common genetic associations with both familial and sporadic Parkinson's disease, making this research directly relevant to understanding a major neurodegenerative condition affecting millions globally. The consolidated grant distribution reflects federal prioritization of neuroscience research with translational potential for understanding disease mechanisms and improving clinical outcomes.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.